Quantitative assessment of myocardial perfusion during graded coronary artery stenoses by intravenous myocardial contrast echocardiography  by Leistad, Elisabeth et al.
Quantitative Assessment of Myocardial Perfusion
During Graded Coronary Artery Stenoses by
Intravenous Myocardial Contrast Echocardiography
Elisabeth Leistad, MD, PHD,*† Koji Ohmori, MD, PHD,* Thomas A. Peterson, BSC,*
Geir Christensen, MD, PHD,* Anthony N. DeMaria, MD, FACC, MACC*
San Diego, California and Oslo, Norway
OBJECTIVES The purpose of this study was to examine whether coronary stenoses of variable severity could
be quantitatively assessed by analysis of myocardial perfusion as determined by intravenous
(IV) myocardial contrast echocardiography.
BACKGROUND Recently, new contrast agents and imaging technology have been developed that may enable
improved assessment of myocardial perfusion by IV contrast injection.
METHODS Variable obstruction of the left anterior descending (LAD) coronary artery in dogs was
produced by a screw occluder. Coronary artery flow was measured with a transit time
flowmeter during baseline, pharmacological vasodilation, a non-flow-limiting stenosis at rest
in conjunction with vasodilation, a flow-limiting stenosis, and total occlusion. Myocardial
contrast echocardiography was performed after IV injection of the contrast agent NC 100100.
Time-intensity curves were obtained off-line for the LAD risk area and the adjacent left
circumflex (LCx) territory, and peak background-subtracted video intensity was determined.
Fluorescent microspheres were injected at each intervention for determination of regional
myocardial blood flow.
RESULTS During non-flow-limiting stenosis, flow limiting stenosis and total occlusion, LAD/LCx
ratios of peak myocardial videointensity and blood flow decreased proportionately. Both
LAD/LCx ratios of video intensity and blood flow identified the non-flow-limiting and the
flow-limiting stenoses as well as total occlusion of the LAD artery. A significant correlation
between LAD/LCx video intensity and blood flow ratios was observed (r 5 0.83, p ,
0.0001).
CONCLUSIONS The degree of blood flow mismatch between ischemic and normal myocardial regions during
graded coronary stenoses can be estimated in the dog by quantitative assessment of myocardial
perfusion produced by IV myocardial contrast echocardiography. (J Am Coll Cardiol 2001;
37:624–31) © 2001 by the American College of Cardiology
The ability to evaluate myocardial perfusion by a quick and
simple noninvasive method would be of great value in
patients with coronary heart disease. Myocardial contrast
echocardiography (MCE) is a promising method for the
assessment of myocardial perfusion. The injection of con-
trast produces increased ultrasonic signals that opacify the
myocardium if myocardial perfusion is normal. Although
the opacification is generally uniform in the setting of
normal flow, a number of variables typically result in some
heterogeneity of regional intensities. Areas of myocardial
ischemia or infarction are usually accompanied by perfusion
defects, and contrast echocardiography has been validated
for the assessment of risk area during total coronary occlu-
sion with intra-arterial injections of contrast (1,2). Recent
development of second-generation contrast agents contain-
ing microbubbles that traverse the pulmonary circulation
has made it possible to obtain myocardial opacification after
intravenous (IV) injection of contrast (3–5), and coronary
stenoses have been evaluated by venous injections of other
contrast agents (6–9). However, the ability of IV contrast
echocardiography to assess myocardial perfusion quantita-
tively during graded coronary stenoses with and without
stress has not been fully determined. The aim of the present
study was to assess myocardial perfusion by MCE after IV
injection of contrast during graded coronary stenoses and
total coronary artery occlusion.
METHODS
Animal preparation. The study was approved by the An-
imal Research Committee at the University of California–
San Diego and conformed to the “Principles of the Amer-
ican Heart Association on Research Animal Use,” (AHA,
November 11, 1984). Eight mongrel dogs were anesthe-
tized, intubated and ventilated with a respirator. Arterial
blood gases and pH and body temperature were kept within
normal limits. The heart was exposed through a left lateral
thoracotomy and suspended in a pericardial cradle. Cathe-
ters were introduced into the pulmonary artery, left atrium,
left ventricle (LV), femoral veins and femoral artery to
inject, withdraw, and measure pressures. The proximal
portion of the left anterior descending coronary artery
From the *Cardiovascular Division, University of California at San Diego, San
Diego, California, and the †Department of Medicine, Lovisenberg Hospital, Oslo,
Norway. Elisabeth Leistad was supported by educational grants from the Unger-
Vetlesen Medical Research Fund, Jersey, C.I.; the Caroline Musaeus Aarsvolds Fund,
Oslo, Norway; the Norwegian Research Council, Oslo, Norway; and the Fulbright
Foundation. This study was presented in part at the 70th Scientific Sessions of the
American Heart Association, Orlando, Florida, 1997.
Manuscript received August 1, 1998; revised manuscript received September 1,
2000, accepted October 13, 2000.
Journal of the American College of Cardiology Vol. 37, No. 2, 2001
© 2001 by the American College of Cardiology ISSN 0735-1097/01/$20.00
Published by Elsevier Science Inc. PII S0735-1097(00)01127-X
(LAD) was dissected free from the surrounding tissue and a
custom-designed screw occluder and a transit-time flow
probe (Transonics series 2RB) connected to a digital flow-
meter (model T201, Transonics Systems, Ithaca, New
York) were placed snugly around the vessel.
Experimental protocol. The experimental protocol is
shown in Figure 1. Baseline recordings, MCE and fluores-
cent microsphere injections were obtained when hemody-
namic stability had been achieved approximately 30 min
after instrumentation. Thereafter, vasodilation to approxi-
mately 300% of the baseline LAD flow was induced by
IV infusion of 4 to 8 mg/kg/min WRC-0470 (2-
cyclohexylmethylidenehydrazinoadenosine), a novel adeno-
sine A2A receptor agonist (10) (Discovery Therapeutics,
Richmond, Virginia), and MCE and microsphere injections
were repeated. After the vasodilator was discontinued and
hemodynamics had stabilized, a stenosis that was not flow
limiting at rest was created on the LAD. Vasodilation was
again induced, and MCE and microsphere injections were
performed. After return to baseline, subsequent MCE and
fluorescent microsphere injections were performed during a
flow-limiting stenosis at rest obtained by tightening the
occluder to approximately 50% of resting LAD blood flow.
Each period of flow reduction lasted between 10 and
15 min. The last intervention was a total LAD occlusion
that was maintained throughout the rest of the study
(approximately 15 min until euthansia). Hemodynamic
variables were monitored continuously and recorded prior
to, and 1 and 3 min following injection of the contrast
agent, after which fluorescent microspheres were injected to
determine regional myocardial blood flow. A minimum of
30 min were allowed between each contrast injection.
MCE. The contrast agent used in this study, NC 100100,
consists of a proprietary formulation of perfluorocarbon
microbubbles in a shell (11), and was provided by Nycomed
Imaging (Oslo, Norway). After reconstitution of the powder
with sterile water to a homogeneous solution containing
17.5 million microbubbles/ml, 2.5 ml of the suspension of
contrast agent per kilogram mixed with 0.5 ml dextrose was
manually injected intravenously as a bolus over 3 to 4 s via
the short catheter in the femoral vein and flushed with
10 ml saline. The MCE was performed with an ATL HDI
3000 echocardiograph (ATL, Bothell, Washington)
equipped with a broadband 4–7-MHz transducer. Har-
monic two-dimensional imaging in short axis view at the
level of the papillary muscle was performed during trigger-
ing on the R-wave of every beat. End-diastolic triggering
was chosen because it is less dependent on changes in heart
rate, the images are easier to align than those obtained with
end-systolic triggering, and coronary flow is maximal in
diastole. The energy to the microbubbles was kept constant
by employing the same mechanical index (0.4) and focus
depth for all animals, which produced fairly homogenous
opacification with every heart beat during triggered imaging
at baseline. Imaging gain settings were optimized and
thereafter kept unchanged. A linear postprocessing curve
was used. A latex bag filled with degassed saline functioned
as an acoustic interface between the surface of heart and the
transducer. The transducer was placed within the bag,
affixed to a metal stand clamped to the operating table, and
positioned in order to obtain an image of the LAD and
adjacent left circumflex coronary artery (LCx) beds. The
data were recorded on 1.25-cm SVHS videotape, and
recordings were obtained from 30 s prior to, until 4 min
after, injection of contrast.
Echocardiographic images were analyzed with an off-line
computer system (Tomtec Imaging Systems, Boulder, Col-
orado). Starting with approximately 15 beats prior to the
injection of contrast, 100 consecutive end-diastolic frames
were digitized with 640 3 480 pixel resolution on a scale of
256 gray levels and transferred to the memory of the
computer. The LAD bed was identified as the region
demonstrating a perfusion defect during total occlusion.
Transmural regions of interest, including as much of the
anterior myocardium as possible, were drawn in the LAD
and the LCx beds, avoiding the bright endocardial and
epicardial borders (Fig. 2, left) and adjusted manually to
correct for motion of the heart. The shape and size of the
region of interest were constant in all experiments. Back-
ground intensity (average video intensity from the 15 beats
in the region of interest before injection of contrast) was
subtracted from the peak intensity (average of the three
highest data points) in the same region after injection of
contrast (Fig. 2, right). The variation in the precontrast
Abbreviations and Acronyms
ECG 5 electrocardiography
LAD 5 left anterior descending coronary artery
LCx 5 left circumflex coronary artery
LV 5 left ventricle/left ventricular
MCE 5 myocardial contrast echocardiography
SPECT 5 sestamibi single-photon emission
computed tomography
WRC-0470 5 2-cyclohexylmethylidenehydrazinoadenosine
Figure 1. The outline of the study protocol. MCE 5 myocardial contrast echocardiography; MBF 5 myocardial blood flow assessed with fluorescent
microspheres; NFLS 1 Vasodilation 5 non-flow-limiting stenosis at rest in conjunction with vasodilation.
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echocardiographic signal intensity was low, with a coeffi-
cient of variation of 6.5% for five repetitive measurements in
the same dog and 4.4% variation between dogs. The
coefficient of variation between the peak echocardiographic
signal intensities measured from three contrast injections in
the same animal was on average 7.0%.
Myocardial blood flow measurements. Approximately
10 3 106 fluorescent microspheres (Molecular Probes,
Eugene, Oregon) suspended in saline, 0.02% Tween-20 and
0.02% thimerosal, were injected into the left atrium at each
intervention. Reference blood samples were withdrawn
from the femoral artery over 60 s with a constant-rate
withdrawal pump starting 5 s prior to injection of micro-
spheres. The short-axis slice of the LV corresponding to the
echocardiographic image was identified by piercing the
heart with spinal needles in the plane of the transducer after
the last intervention. At the end of the experiment the dog
was sacrificed and the heart excised with the spinal needles
in place. Evans blue dye (Sigma Chemical, St. Louis,
Missouri) was injected into the coronary ostia while the
occlusion of the LAD remained on the vessel. This proce-
dure stained the nonischemic myocardium blue, while the
ischemic LAD bed was left unstained. The heart was cut
along its short axis into 1-cm-thick slices. The myocardial
slice corresponding to the image of the MCE was identified
as described above. Three wedge-shaped specimens from
the ischemic and three from the nonischemic myocardium
were divided into epicardial and endocardial portions. The
specimens were weighed and processed for determination of
myocardial blood flow by spectrofluorometry according to
the standard method described by Glenny et al. (12).
Statistics. The data were analyzed with a one-way repeated
measurements analysis of variance with a Student Newman-
Keuls extension for multiple comparisons. When comparing
the means of two different sets of data, an unpaired t test
was used. Correlation between LAD/LCx video intensity
ratio and regional blood flow ratio was performed with
linear regression analysis. A p value of p , 0.05 was
considered statistically significant. All values are presented
as means 6 SEM.
RESULTS
Technically adequate studies with visible contrast opacifi-
cation of the myocardium were obtained in all animals.
After injection of the contrast agent there was no significant
change in the baseline hemodynamic values. Moreover, no
significant changes in the hemodynamic values occurred
during the experiments (Table 1). Administration of the
vasodilator WRC-0470 in the doses used in this study did
not have any significant hemodynamic effect on other
parameters than myocardial blood flow measured by the
flow-meter. These parameters were also unchanged during
and after injection of the fluorescent microspheres.
Figure 3 shows short axis end-diastolic video images of
the LV at the papillary muscle level from each intervention
Figure 2. Representative echocardiogram illustrating left anterior descending (region in solid line) and left circumflex (region in dotted line) coronary
artery perfusion territories (left panel) and the time-intensity curves derived from these regions during a flow-limiting stenosis (right panel).
Table 1. Hemodynamic Parameters
Baseline Vasodilation
NFLS 1
Vasodilation FLS Total Occ
LVSP (mm Hg) 111 6 7 117 6 5 110 6 6 109 6 7 112 6 6
Mean AP (mm Hg) 109 6 6 106 6 7 102 6 9 102 6 8 102 6 8
Mean PAP (mm Hg) 16 6 1 17 6 1 18 6 2 19 6 2 19 6 2
HR (beats/min) 139 6 5 135 6 7 138 6 6 138 6 6 138 6 5
Flow LAD (ml/min) 19 6 2 55 6 6* 30 6 5*† 10 6 1*† 0*†
*p , 0.05 vs. baseline; †p , 0.05 vs. vasodilation. Values are means 6 SEM.
AP 5 arterial pressure; FLS 5 flow-limiting stenosis; HR 5 heart rate; LAD 5 left anterior descending coronary artery; LVSP 5 left ventricular systolic pressure; NFLS 1
Vasodilation 5 non-flow-limiting stenosis at rest in conjunction with vasodilation; PAP 5 pulmonary artery pressure; Total Occ 5 total occlusion.
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in one representative dog. The transducer was positioned on
the anterior LV wall to record both LAD and LCx regions
at the top of the image and to minimize attenuation from
the right ventricular cavity. Before contrast injection the
homogenous LV cavity appears black and the myocardium
exhibits minimal reflections apart from the epicardial and
endocardial borders (Fig. 3, upper left). After contrast
injection there was an apparent homogenous opacification
of the entire anterior wall including LAD and LCx regions
(Fig. 3, upper right). During pharmacological vasodilation a
further increase in the intensity of myocardial opacification
was apparent (Fig. 3, middle left). During the non-flow-
limiting stenosis, pharmacological vasodilation caused the
LCx region to appear brighter than the LAD region (Fig. 3,
middle right); brightness in the LCx region was similar to
the brightness in the previous picture. During the flow-
limiting stenoses (Fig. 3, lower left) there is fairly good
opacification of the LCx region, but only weak, speckled
opacification of the LAD region. During the total LAD
occlusion a perfusion defect is clearly shown in the LAD
region, whereas the LCx region shows normal opacification
(Fig. 3, lower right).
Changes in blood flow in the LAD observed during the
various interventions applied are depicted in Figure 4. LAD
blood flow at baseline measured 19 6 2 ml/min, and it
nearly tripled with vasodilation to 55 6 6 ml/min. In the
setting of a non-flow-limiting stenosis and pharmacological
vasodilation, LAD flow was 30 6 5 ml/min, while the
flow-limiting stenosis reduced LAD blood flow to 10 6
1 ml (both p , 0.05). Total occlusion resulted in an absence
of measurable LAD blood flow by the transit time method.
The changes in the ratios of LAD/LCx regional myocar-
dial blood flow and background-subtracted video intensity,
which accompanied the alterations in LAD blood flow, are
shown in Figure 5. At baseline, the LAD/LCx regional
blood flow ratio measured by microspheres was 1.07 6 0.07,
a value similar to the video intensity ratio of 0.98 6 0.10.
Vasodilation produced relatively little change in LAD/LCx
ratio in either value; regional blood flow ratio was 1.07 6
0.11 and the video intensity ratio was 0.9 6 0.1 (difference
between ratios 5 NS). The combination of non-flow-
Figure 3. Echocardiograms during specific interventions in a representative experiment. End-diastolic echocardiographic images of the anterior half of the
left ventricle in short-axis are shown. Upper left: Precontrast, prior to contrast injection; upper right: Baseline, after contrast injection; middle left:
Vasodilation, during pharmacological vasodilation; Middle right: NFLS 1 Vasodilation, a non-flow-limiting LAD stenosis at rest in conjunction with
pharmacological vasodilation; lower left: FLS, a flow limiting stenosis that reduces coronary blood flow by 50% at rest; lower right: Total Occ; total
occlusion of the LAD. Arrows depict the border between the LAD and LCx region. LAD 5 left anterior descending coronary artery; LCx 5 left circumflex
coronary artery.
Figure 4. Graph showing left anterior descending coronary artery (LAD)
flow measured by transit-time flowmeter during the various interventions.
NFLS 1 Vasodilation 5 non-flow-limiting stenosis at rest in conjunction
with vasodilation; FLS 5 flow-limiting stenosis; Total Occ 5 total
occlusion. *p , 0.05 vs. baseline; †p , 0.05 vs. vasodilation.
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limiting stenosis and pharmacological vasodilation reduced
the ratio of LAD/LCx values both in terms of blood flow
(0.81 6 0.1, p , 0.05) and video intensity (0.68 6 0.08,
p , 0.05), which were further reduced by a flow-limiting
stenosis to 0.63 6 0.07 and 0.59 6 0.08, respectively. The
lowest LAD/LCx ratio values were observed in the presence
of total occlusion, where a visually apparent contrast defect
was observed in all animals, and measured 0.14 6 0.05 for
both flow and video intensity (both p , 0.05 vs. baseline).
The results of linear regression analysis between
background-subtracted video intensity and blood flow ratios
derived from a total of 40 flow states are shown in Figure 6,
left panel (y 5 0.96x 1 0.11). There is a good correlation
between the two variables (r 5 0.83, p , 0.0001, SEE 5
0.24). Figure 6 (right panel) shows the results normalized to
the baseline values for each dog (y 5 0.97x 1 0.01). The
correlation coefficient observed for normalized data was 0.93
(p , 0.001, SEE 5 0.15).
During baseline, the precontrast video intensity in the
LAD region of 60 6 4 gray levels was similar to the 57 6
2 gray levels in the LCx region (difference: NS). There was
no significant difference between the precontrast video
intensities in the LAD and LCx region at any of the
interventions. Furthermore, the video intensities prior to
injection of contrast remained constant throughout the
experiment.
DISCUSSION
Despite limitations of spatial definition and variables capa-
ble of influencing contrast-intensity measurements, the
present study demonstrates that MCE provides a reliable
method for assessing myocardial perfusion after IV injection
of contrast in dogs. Our data establish that the myocardial
video intensity ratio between ischemic and normal myocar-
dial regions is altered in the presence of coronary stenoses.
We demonstrate that the degree of reduction in video
intensity ratio differs for variable grades of coronary obstruc-
tion, and it correlates significantly with the degree of blood
flow mismatch. Moreover, our data show that reduced
perfusion with non-flow-limiting stenoses at rest can be
reliably assessed by IV MCE in conjunction with pharma-
cological vasodilation, and that reduced perfusion with
stenoses that are flow limiting at rest or total coronary artery
occlusion can be evaluated without pharmacological vasodi-
lation.
Assessment of myocardial perfusion during non-flow-
limiting stenosis. Data regarding the quantitative assess-
ment of relative myocardial perfusion during non-flow-
limiting coronary stenoses are few, even with echocardiography
obtained by intracardiac injection of contrast (13–15). How-
ever, a few studies of graded coronary stenoses have dem-
onstrated good correlation between the ratios derived from
normal and ischemic myocardium for video intensity and
regional myocardial blood flow after both intra-aortic (13)
and left or right atrial injection of contrast (11). After
complex analysis with magnification of video intensity
Figure 5. Graph showing the ratio between left anterior descending
(LAD) and left circumflex (LCx) coronary artery background-subtracted
peak video intensity and regional myocardial blood flow during various flow
states. Abbreviations as in Figure 3. *p , 0.05 vs. baseline; †p , 0.05 vs.
vasodilation.
Figure 6. Graphs showing relation between the ratio of left anterior descending and left circumflex coronary artery (LAD/LCx) background-subtracted
peak video intensity (x-axis) and regional myocardial blood flow measured by fluorescent microspheres (y-axis) before (left panel) and after normalization
to the baseline values for each animal (right panel).
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measurements from ischemic and normal myocardium,
Firschke et al. (8) were able to demonstrate perfusion
mismatch during pharmacological vasodilation after venous
injection of FS-069. Wei et al. (16) used another contrast
agent (AFO150) to study stenoses that produced pressure
gradients of variable severity. They examined only stenoses
that were non-flow-limiting at rest, and only during hyper-
emia, and they showed a correlation between the ratio of
peak video intensity and myocardial blood flow in the
stenosed to normal beds. Our findings confirm these results
with non-flow-limiting stenoses at rest using another con-
trast agent, diastolic gating, and standard quantitative
methods.
Assessment of myocardial perfusion during flow-limiting
stenosis. In the present study we found that stenoses that
were flow limiting at rest significantly reduced the ischemic-
to-normal myocardial contrast-intensity ratio. This demon-
strates for the first time that IV MCE can detect a decreased
intensity produced by severe stenoses without the need for
pharmacological vasodilation. Previously, flow-limiting ste-
noses have required pharmacological hyperemia to quantify
myocardial blood flow with contrast echocardiography, even
after injection of contrast into the aortic root (14,16).
Coronary vasodilators have well-known potential side ef-
fects, including hypotension and chest pain, and patients
with severe lesions may be more vulnerable to such side
effects. Hence, the assessment of coronary stenoses without
pharmacological vasodilation would be advantageous in the
clinical setting.
Assessment of myocardial perfusion during total coro-
nary occlusion. During total occlusion of the LAD we
observed a visible perfusion defect in all dogs, and we found
that the ratio between ischemic and normal myocardial
regions was similar for both blood flow and video intensity.
Perfusion defects after IV injection of contrast have previ-
ously been demonstrated to correlate with area at risk or
infarct size expressed as the magnitude of wall-motion
abnormalities or by means of tissue staining (3,4,7). In
addition, the location and reversibility of perfusion abnor-
malities detected by IV MCE have been found to be similar
to that depicted by sestamibi single-photon emission com-
puted tomography (9). Because of lateral dropout of the
echocardiographic image in our study, which was most
likely related to anisotropy of fiber orientation (17), the
posterior borders of the LAD and LCx beds could not be
defined. Thus, the absolute size of the perfusion defect was
not measured.
In a carefully performed study using somewhat different
methodology, Meza et al. (6) found that peak contrast
intensity during coronary occlusion showed a modest but
significant correlation to blood flow measured by radiola-
beled microspheres, after normalization of the ultrasound
peak intensity values to baseline. In our study, however,
normalization of the intensity values to baseline was not
necessary to obtain a significant correlation to regional
blood flow. The importance of this becomes evident in the
clinical setting of coronary occlusions where a normal
baseline contrast echocardiogram is rarely available for
evaluation of patients with coronary heart disease.
Factors affecting video intensity during contrast echocar-
diography. The precise mechanism for the changes in
video intensity remains unresolved. However, as described
below, several alternatives are possible. The video intensity
is related to the number of microbubbles within the ultra-
sound beam (18), which depends on blood volume and
microbubble transit rate through the imaging field. Further-
more, video intensity measurements are affected by ultra-
sound power (18,19), which can lead to destruction of
microbubbles and to a decrease in microbubble size. In our
study, microbubbles were probably destroyed by ultrasound,
even though a mid-range ultrasound power and triggered
imaging were used. Based on a maximal transit velocity in
myocardial capillary arterioles and vessels, the 4 to 5 mm
thickness of the ultrasound beam, and the heart rate of 135,
the interval between each heart beat would be too short for
complete replenishment of new bubbles, and the video
intensity would be influenced by destruction of micro-
bubbles during the previous exposure.
An alternative mechanism for the change in video inten-
sity involves the fact that blood volume and transit rate
increase during vasodilation (20). In the presence of a
non-flow-limiting stenosis at rest combined with hyper-
emia, it has been shown that the vasodilator-induced
increase in both flow and blood volume is less in the
myocardium distal to a stenosis than in the normal bed
(21–23). Hence, video intensity in the ischemic region
would be reduced compared to the normal region and thus
the video intensity ratio would be decreased similarly to the
myocardial blood flow ratio.
It has now been shown that the time-course of replen-
ishment of microbubbles into the imaging field following
bubble destruction is a function of flow velocity and cross-
sectional microvascular volume (24). These determinants
are expressed as the rate of intensity increase and the peak
plateau intensity, respectively. Thereby, the replenishment
of contrast intensity can be fit by the exponential function
Y 5 A(1 2 ebt), where b represents the rate of increase and
A represents peak intensity. The fact that A decreases
following vasodilation in the presence of stenosis is evidence
of reduced microcirculatory blood volume and supports the
concept that capillary closure or derecruitment to maintain
perfusion pressure is the mechanism for reduced contrast
intensity in the bed of stenotic vessels.
Methodological considerations. Although reproducibility
of peak contrast intensities between animals is limited, our
study revealed a low variation when assessments of peak
signal intensities were determined by repetitive injections of
contrast in the same animal. Hence, we compared video
intensity ratios to blood flow ratios in an ischemic and
normal myocardial region in the same animal. In the
presence of generalized disease of all three coronary vessels,
equivalent reductions in flow might mask hypoperfusion.
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However, assessing relative changes in myocardial perfusion
by comparing ratios between ischemic and normal myocar-
dial regions is a widely used method for evaluation of
coronary stenoses.
Measuring Doppler velocity reserve in individual coro-
nary arteries may obviate this problem in the future (25). In
our study, the peak value derived from the time-intensity
curve was used to assess changes in myocardial blood flow
with MCE. Because the relation between video intensity
and myocardial blood flow is linear only at low concentra-
tions of microbubbles (26), we used a low dose of the
contrast agent. This dose produced homogenous myocardial
opacification during baseline conditions. To compare dif-
ferences in video intensity during various interventions, it is
imperative that the baseline does not change during the
experiment (23). No significant changes occurred in the
baseline values before the various contrast injections in the
LAD or the LCx region during our experiments. Although
there was a trend toward a reduction in myocardial back-
scatter during the flow-limiting stenosis and total occlusion,
this did not reach statistical significance in our study. This
might be related to the fact that echocardiographic images
were obtained shortly after coronary occlusion before the
development of histopathological changes in the myocardial
tissue.
In the previous studies cited, the pharmacological hyper-
emia necessary to identify ischemia was produced by vaso-
dilators, such as dipyridamole, dobutamine, or adenosine
(7). In the current protocol, vasodilation was produced by
infusion of WRC-0470, a novel adenosine A2A receptor
agonist-producing coronary vasodilator without the hypo-
tensive effect of traditional vasodilators (10). In our study,
no significant hemodynamic effects were observed with
WRC-0470 infusion, other than the increase in coronary
blood flow. Because changes in aortic pressure and heart rate
would affect myocardial perfusion, the avoidance of signif-
icant alterations in these parameters is important for eval-
uating myocardial perfusion.
Clinical implications. Our study establishes the ability to
assess graded coronary stenoses from MCE in open-chest
dogs with high-quality echocardiographic images. Trans-
thoracic imaging in humans may be compromised by
attenuation from the chest wall and lung, as well as by
artifacts and a lesser signal-to-noise ratio. Shadowing at
peak contrast intensity can be reduced by imaging from
apical views.
Because the methods used in this study relate to a ratio
between contrast intensity between ischemic and normal
myocardial regions, it is reasonable to expect similar results
for lower doses of contrast or measurements at a later time
after the injection of contrast.
To compare myocardial regions with different blood flow
values in our experiments, adjacent myocardial regions from
the anterior aspect of the left ventricle were evaluated.
Whether the results of our study will be reproduced with
ischemia in other areas remains the subject of further
investigation. However, our data indicate that IV MCE
may prove suitable both for the detection of myocardium at
risk of ischemia during pharmacological stress and for the
detection of manifest stenoses and coronary occlusions, even
in the absence of pharmacological intervention. Finally,
these data establish the potential of myocardial perfusion by
IV MCE to be a valuable diagnostic tool in the assessment
of patients with coronary heart disease.
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